Search Results

ACCC president Olalekan Ajayi, PharmD, MBA, shared the association’s key priorities for impacting cancer care in the United States with the President’s Cancer Panel.

Over half of patients newly diagnosed with multiple myeloma are not eligible for transplant due to age or other major health problems. Listen as Dr. Yee provides treatment planning options available to patients who are ineligible for transplant.

As interest continues to build around multi-cancer early detection, hear what care teams need to know about the technology and the legislative outlook for coverage for this revolutionary testing.

In recognition of September as prostate cancer month, ACCCBuzz reviews the current landscape of prostate cancer care.

ACCC applauds President Biden for renewing the Cancer Moonshot and setting the ambitious goals of reducing cancer mortality while improving the experience of patients living with cancer.

ACCC joined nearly 100 provider and patient organizations in supporting President Biden’s renewed Cancer Moonshot and its efforts to advance cancer prevention, early detection, treatment, and research. The letter asks Congress to provide necessary funding for the Moonshot’s initiatives.

Read how the Cancer Moonshot aims to improve the experience of people and their families living with and surviving cancer by increasing cancer screenings, increasing access to clinical trials, and investing in new treatments, among other initiatives.

On Sept. 21, the Biden Cancer Initiative Summit convened in Washington, D.C., and was joined by 450 community summits across the country to bring together those who work to improve the cancer experience for patients and caregivers.

As we head into a New Year with a new Administration in the White House, we can be certain that now more than ever the oncology community must continue to be the strong, clear voice for access to quality cancer care delivery in all settings of care.

On January 12, 2016, President Obama used his State of the Union address to announce that Vice President Biden would be leading a national moonshot to end cancer as we know it.

The Moonshot Summit brought together a diverse group of stakeholders, including cancer patients, advocacy groups, researchers, providers, and members of industry, including technology, IT, and drug development.